GB201712952D0 - Immunomodulatory agent - Google Patents

Immunomodulatory agent

Info

Publication number
GB201712952D0
GB201712952D0 GBGB1712952.9A GB201712952A GB201712952D0 GB 201712952 D0 GB201712952 D0 GB 201712952D0 GB 201712952 A GB201712952 A GB 201712952A GB 201712952 D0 GB201712952 D0 GB 201712952D0
Authority
GB
United Kingdom
Prior art keywords
immunomodulatory agent
immunomodulatory
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1712952.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Priority to GBGB1712952.9A priority Critical patent/GB201712952D0/en
Publication of GB201712952D0 publication Critical patent/GB201712952D0/en
Priority to PCT/GB2018/052298 priority patent/WO2019030542A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
GBGB1712952.9A 2017-08-11 2017-08-11 Immunomodulatory agent Ceased GB201712952D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1712952.9A GB201712952D0 (en) 2017-08-11 2017-08-11 Immunomodulatory agent
PCT/GB2018/052298 WO2019030542A1 (en) 2017-08-11 2018-08-13 Immunomodulatory agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1712952.9A GB201712952D0 (en) 2017-08-11 2017-08-11 Immunomodulatory agent

Publications (1)

Publication Number Publication Date
GB201712952D0 true GB201712952D0 (en) 2017-09-27

Family

ID=59896151

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1712952.9A Ceased GB201712952D0 (en) 2017-08-11 2017-08-11 Immunomodulatory agent

Country Status (2)

Country Link
GB (1) GB201712952D0 (en)
WO (1) WO2019030542A1 (en)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4957735A (en) 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5004697A (en) 1987-08-17 1991-04-02 Univ. Of Ca Cationized antibodies for delivery through the blood-brain barrier
US5055303A (en) 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5268164A (en) 1990-04-23 1993-12-07 Alkermes, Inc. Increasing blood-brain barrier permeability with permeabilizer peptides
US5254342A (en) 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
JPH07507768A (en) 1992-03-12 1995-08-31 アルカーメス　コントロールド　セラピューティクス，インコーポレイテッド Controlled release of ACTH-containing microspheres
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5514670A (en) 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
PL200134B1 (en) 1999-05-07 2008-12-31 Genentech Inc Treatment of autoimmunologic diseases with antagonists binding to cell surface markers
US10703799B2 (en) * 2012-12-10 2020-07-07 Vib Vzw IL-33R and IL-1RAcP fusion proteins
BR112018014247A2 (en) * 2016-01-14 2018-12-18 Anaptysbio Inc allergic reaction inhibition using an il-33 inhibitor

Also Published As

Publication number Publication date
WO2019030542A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
DK3606954T3 (en) Anti-LAG3-antistoffer
SG11201912537PA (en) Exoskeleton
DK3734167T3 (en) Airconditionsystem
SI3094351T1 (en) Immunomodulatory agents
DK3499914T3 (en) Høreapparatsystem
DK3700925T3 (en) Hidtil ukendt t-cellereceptor
PL3481933T3 (en) Anti-greying agent
AU201714106S (en) Mandoline
DK3401557T3 (en) Træskrue
DK3485765T3 (en) Computerbord
DK3630041T3 (en) Stimulationsapparat
PT3206676T (en) Supporting immunomodulatory agent
DK3718525T3 (en) Motoriseret asssistancesystem
SG11202002687UA (en) Immunomodulatory oligosaccharides
DK3704866T3 (en) Datatransmissionssystem
GB201714777D0 (en) Agent
GB201620641D0 (en) Agent
GB201700825D0 (en) Poliovaccine
GB201715101D0 (en) Protection apparatus
GB201702641D0 (en) Easpagnolette
GB201712952D0 (en) Immunomodulatory agent
DK3425793T3 (en) Tagsystem
DK3618761T3 (en) Intrakorporalt perfusionssystem
DK3351149T3 (en) Syltetøjsfontæne
AU201715236S (en) Striplight

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)